Richard Labelle

Richard Labelle discloses dealings in Pediapharm Inc. to SEDI. Over a trading history stretching from 28 July 2016 to 1 September 2017, the count stands at 7 filings.

Every open-market trade on record is a purchase: 5 purchases worth €11k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.

The median purchase comes to €1,749. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 6 September 2017 with a transaction (€10k) in Pediapharm Inc. The latest purchase dates back some time: it was published 3,743 days ago, on 28 July 2016. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.